Scholars Central

Short communicationPublished 26 Feb 2020

Molecularly targeted therapy for Duchene Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA): Kuwait Experience

Authors: Laila Bastaki

Stem Cell Research and Regenerative Medicine

Volume 3 · Issue 1 · Pages 01

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Spinal muscle atrophy (SMA) is an autosomal recessive motor neuron disease caused by progressive degeneration of motor neurons in the spinal cord and in specific motor nuclei of the brainstem (cranial nerve nuclei V, VII, IX, and XII). The disease causes the voluntary muscles to become sluggish and wasted. Symptoms of spinal muscle atrophy differ, and may be mild or disabled, but include a muscle weakness which controls movement. Involuntary muscles are not affected, such as those in the heart, the blood vessels and the digestive tract. SMA weakens the muscles that are nearest to the body's core, including the elbows, knees, thighs and upper back. Within the spine (scoliosis) the affected child can develop a curve due to loss of size and strength of the back muscles. SMA development can also affect respiration and chewing, which can endanger the patient's life.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Stem Cell Research and Regenerative Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalStem Cell Research and Regenerative Medicine
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Laila Bastaki”